Cell Therapy With Mesenchymal Stem Cell in Ischemic Limb Disease

Clinical trial NCT02336646 · COMPLETED

Trial details

NCT number: NCT02336646
Sponsor: Taiwan Bio Therapeutics Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Critical Limb Ischemia

Start date: 2015-05-01
Primary completion: 2018-04-27
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.